National Audit Day 2025

Our National Audit Day took place in Royal College of Pathologists on 28 Nomber 2025. It was an excellent opportunity to hear about both national and local audits carried out by clinical scientists and medical staff working in laboratory medicine as well as forthcoming audits. The day focused on prostate cancer, testosterone treatment and cancer biomarkers.

Programme

9.30am Welcome and introduction, W Wassif, National Audit Lead
9.35am  National audit of the laboratory investigation of PSA for the diagnosis and monitoring of prostate cancer, Andrew Seggie and Abel Tesfai, Prostate Cancer UK
10.05am  Detection, assessment, surveillance, and management of prostate cancer, Caroline Moore, Professor and Honorary Consultant Urological Surgeon University College Hospital, London
10.45am  Patient perspective, Neil MacLachlan

11.00am  Tea Break

11.15am  National Audit on testosterone, Nicola Barlow, Black Country Pathology Services
11.45am Outcomes of testosterone treatment in pathological and functional male hypogonadism, Richard Quinton, Consultant Endocrinologist, Newcastle Hospitals Trust
12.25am Discussion
12.35am New oncological therapeutics - 50 ways to kill your cancer, Kathryn Hawkesford Consultant Medical Oncologist, Barts Health NHS Trust

1.15pm Lunch and poster session

2.15pm National audit on tumours markers, Louise Ward, Bedford Hospital NHS Trust and Peter West, South Thames Audit Group
2.45pm The provision of laboratory services for tumour markers, Cathie Sturgeon Department of Laboratory Medicine, Edinburgh Royal Infirmary

3.15pm Tea break

3.30pm Circulating DNA (ctDNA): A potentially transformative tumour marker, Michael Duffy Professor at Clinical Research Centre St Vincent's University Hospital, Dublin, Ireland
4.00pm Personalized medicine - clinical implications of molecular profiling of tumours, an update, Shahzad Qureshi Consultant Histopathologist, Bedfordshire Hospitals NHS Foundation Trust
4.30pm Regional audit presentations
Improving Post-Discharge Iron Monitoring in Heart Failure Patients Treated with Intravenous Iron: A Closed-Loop Retrospective Audit, Christos Charalambous
Assessing performance of LDL-C assayed by direct method compared to calculation by Friedewald and Sampson equations to improve the provision of lipid lowering therapy, Tanmin Rahman
5.00pm Discussion
5.10pm Feedback and closing remarks, W Wassif, National Audit Lead